Low concentrations of 1, 25-dihydroxyvitamin D3 reduce phosphate absorption in the intestinal tract and promote secondary hyperparathyroidism, resulting in hyperphosphatemia, vitamin D deficiency, and increased parathyroid hormone levels. The gene discussed is PTH; the disease is vitamin D deficiency.